148 related articles for article (PubMed ID: 17465474)
1. Clinical heterogeneity in autoimmune acute liver failure.
Chavez-Tapia NC; Martinez-Salgado J; Granados J; Uribe M; Tellez-Avila FI
World J Gastroenterol; 2007 Mar; 13(12):1824-7. PubMed ID: 17465474
[TBL] [Abstract][Full Text] [Related]
2. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.
De Martin E; Coilly A; Chazouillères O; Roux O; Peron JM; Houssel-Debry P; Artru F; Silvain C; Ollivier-Hourmand I; Duvoux C; Heurgue A; Barge S; Ganne-Carrié N; Pageaux GP; Besch C; Bourlière M; Fontaine H; de Ledinghen V; Dumortier J; Conti F; Radenne S; Debette-Gratien M; Goria O; Durand F; Potier P; Di Martino V; Reboux N; Ichai P; Sebagh M; Mathurin P; Agostini H; Samuel D; Duclos-Vallée JC;
J Hepatol; 2021 Jun; 74(6):1325-1334. PubMed ID: 33503489
[TBL] [Abstract][Full Text] [Related]
3. Steroid use in acute liver failure.
Karkhanis J; Verna EC; Chang MS; Stravitz RT; Schilsky M; Lee WM; Brown RS;
Hepatology; 2014 Feb; 59(2):612-21. PubMed ID: 23929808
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure.
Zhu B; You SL; Wan ZH; Liu HL; Rong YH; Zang H; Xin SJ
World J Gastroenterol; 2014 Jun; 20(23):7473-9. PubMed ID: 24966618
[TBL] [Abstract][Full Text] [Related]
6. Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?
Rahim MN; Liberal R; Miquel R; Heaton ND; Heneghan MA
Liver Transpl; 2019 Jun; 25(6):946-959. PubMed ID: 30900368
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome.
Yeoman AD; Westbrook RH; Zen Y; Bernal W; Al-Chalabi T; Wendon JA; O'Grady JG; Heneghan MA
J Hepatol; 2014 Oct; 61(4):876-82. PubMed ID: 24842305
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure.
Anastasiou OE; Dogan-Cavus B; Kucukoglu O; Baba H; Kahraman A; Gerken G; Schramm C; Canbay A
Digestion; 2018; 98(2):104-111. PubMed ID: 29698940
[TBL] [Abstract][Full Text] [Related]
9. Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune Hepatitis.
Noguchi F; Chu PS; Yoshida A; Taniki N; Morikawa R; Hasegawa Y; Yamataka K; Hoshi H; Kasuga R; Tabuchi T; Ebinuma H; Shinoda M; Obara H; Kitagawa Y; Kanai T; Nakamoto N
Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2641-2643.e3. PubMed ID: 34102339
[TBL] [Abstract][Full Text] [Related]
10. Fulminant hepatic failure in autoimmune polyendocrine syndrome type-1.
Sinha R; Chapman AR; Reid GT; Hayes PC
J R Coll Physicians Edinb; 2015; 45(2):136-40. PubMed ID: 26181530
[TBL] [Abstract][Full Text] [Related]
11. Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study.
Díaz-Ramírez GS; Marín-Zuluaga JI; Donado-Gómez JH; Muñoz-Maya O; Santos-Sánchez Ó; Restrepo-Gutiérrez JC
Gastroenterol Hepatol; 2018 Feb; 41(2):87-96. PubMed ID: 29126693
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation.
Czaja AJ
Liver Transpl; 2007 Jul; 13(7):953-5. PubMed ID: 17600348
[No Abstract] [Full Text] [Related]
13. Autoimmune severe acute fulminant hepatic failure (FHF) during pregnancy.
Caballero-Mateos AM; López Garrido MÁ; Becerra Massare P; de Teresa Galván J
Gastroenterol Hepatol; 2018 Apr; 41(4):259-260. PubMed ID: 28579277
[No Abstract] [Full Text] [Related]
14. Black Adult Patients With Acute Liver Failure Are Sicker and More Likely to Undergo Liver Transplantation Than White Patients.
Nephew L; Zia Z; Ghabril M; Orman E; Lammert C; Chalasani N
Liver Transpl; 2019 Nov; 25(11):1634-1641. PubMed ID: 31271697
[TBL] [Abstract][Full Text] [Related]
15. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
Montano-Loza AJ; Carpenter HA; Czaja AJ
Hepatology; 2007 Oct; 46(4):1138-45. PubMed ID: 17668882
[TBL] [Abstract][Full Text] [Related]
16. Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure.
Fujiwara K; Yasui S; Yonemitsu Y; Arai M; Kanda T; Fukuda Y; Nakano M; Oda S; Yokosuka O
J Hepatobiliary Pancreat Sci; 2016 Apr; 23(4):212-9. PubMed ID: 26808231
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Significance of Autoantibodies in Children With Acute Liver Failure.
Narkewicz MR; Horslen S; Belle SH; Rudnick DA; Ng VL; Rosenthal P; Romero R; Loomes KM; Zhang S; Hardison RM; Squires RH;
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):210-217. PubMed ID: 27496798
[TBL] [Abstract][Full Text] [Related]
18. [Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007].
Arteaga-Ortiz L; Buitrón-Santiago N; Rosas-López A; Rosas-Arzate G; Armengolt-Jiménez A; Aguayo A; López-Karpovitch X; Crespo-Solís E
Rev Invest Clin; 2008; 60(6):459-69. PubMed ID: 19378832
[TBL] [Abstract][Full Text] [Related]
19. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.
Mendizabal M; Marciano S; Videla MG; Anders M; Zerega A; Balderramo DC; Tisi Baña MR; Barrabino M; Gil O; Mastai R; Yantorno S; Gadano A; Silva MO
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):644-8. PubMed ID: 25923939
[TBL] [Abstract][Full Text] [Related]
20. Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015.
Fujiwara K; Nakayama N; Kato N; Yokosuka O; Tsubouchi H; Takikawa H; Mochida S;
J Gastroenterol; 2020 Sep; 55(9):888-898. PubMed ID: 32556645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
